BACKGROUND: Long-term xenograft survival can be achieved in hamster hearts transplanted into rats treated with cobra venom factor (CVF) and cyclosporine A (CsA). This phenomenon of "accommodation" is associated with expression of protective genes such as bcl-2, bcl-X(L), and heme-oxygenase-1. We examined whether accommodation could be induced in hamster-to-rat lung xenografts and whether the pattern of protective genes is similar to cardiac xenografts. METHODS: We used hamster-to-rat cardiac and lung xenotransplantation models. Cardiac xenotransplants were treated with CVF+CsA and compared with untreated controls. Lung xenotransplants were treated with either CVF+CsA or FK506 and cyclophosphamide (Cp) and compared with untreated controls. All recipients were killed by 21 days after transplantation. We examined graft survival and protein expression of protective genes, and we performed histologic and immunohistologic analyses. RESULTS: Rejection occurred rapidly in untreated rats. CVF+CsA or FK506+Cp treatment significantly influenced graft survival. Eight of 12 CVF+CsA-treated heart transplants survived 21 days. Seven of 16 CVF+CsA-treated lung grafts and five of 12 FK506+Cp-treated lung xenografts survived 21 days. We observed significant protein expression of bcl-2, bcl-X(L), and heme-oxygenase-1 in cardiac xenografts treated with CVF+CsA at 2, 14, and 21 days after transplantation, compared with normal hamster hearts. We also observed significant expression of these proteins in lung xenografts treated with either CVF+CsA or FK506+Cp at 21 days after transplantation, compared with normal lungs. CONCLUSIONS: Accommodation may be a general phenomenon for all organs, mediated through protective genes. Induction of accommodation does not require disruption of the complement system.
BACKGROUND: Long-term xenograft survival can be achieved in hamster hearts transplanted into rats treated with cobra venom factor (CVF) and cyclosporine A (CsA). This phenomenon of "accommodation" is associated with expression of protective genes such as bcl-2, bcl-X(L), and heme-oxygenase-1. We examined whether accommodation could be induced in hamster-to-rat lung xenografts and whether the pattern of protective genes is similar to cardiac xenografts. METHODS: We used hamster-to-rat cardiac and lung xenotransplantation models. Cardiac xenotransplants were treated with CVF+CsA and compared with untreated controls. Lung xenotransplants were treated with either CVF+CsA or FK506 and cyclophosphamide (Cp) and compared with untreated controls. All recipients were killed by 21 days after transplantation. We examined graft survival and protein expression of protective genes, and we performed histologic and immunohistologic analyses. RESULTS: Rejection occurred rapidly in untreated rats. CVF+CsA or FK506+Cp treatment significantly influenced graft survival. Eight of 12 CVF+CsA-treated heart transplants survived 21 days. Seven of 16 CVF+CsA-treated lung grafts and five of 12 FK506+Cp-treated lung xenografts survived 21 days. We observed significant protein expression of bcl-2, bcl-X(L), and heme-oxygenase-1 in cardiac xenografts treated with CVF+CsA at 2, 14, and 21 days after transplantation, compared with normal hamster hearts. We also observed significant expression of these proteins in lung xenografts treated with either CVF+CsA or FK506+Cp at 21 days after transplantation, compared with normal lungs. CONCLUSIONS: Accommodation may be a general phenomenon for all organs, mediated through protective genes. Induction of accommodation does not require disruption of the complement system.
Authors: R Esquivel-Pérez; A L Rodriguez-Ventura; L M Dorantes; B Ramírez-González; M G López-Santos; R Valdes-Gonzalez Journal: Clin Exp Immunol Date: 2011-04-19 Impact factor: 4.330
Authors: Sol Ji Park; Bumrae Cho; Ok Jae Koo; Hwajung Kim; Jung Taek Kang; Sunghoon Hurh; Su Jin Kim; Hye Jung Yeom; Joonho Moon; Eun Mi Lee; Ji Yei Choi; Ju Ho Hong; Goo Jang; Joing-Ik Hwang; Jaeseok Yang; Byeong Chun Lee; Curie Ahn Journal: Transgenic Res Date: 2014-02-05 Impact factor: 2.788
Authors: Alessandro Cinti; Marco De Giorgi; Elisa Chisci; Claudia Arena; Gloria Galimberti; Laura Farina; Cristina Bugarin; Ilaria Rivolta; Giuseppe Gaipa; Ryszard Tom Smolenski; Maria Grazia Cerrito; Marialuisa Lavitrano; Roberto Giovannoni Journal: PLoS One Date: 2015-10-29 Impact factor: 3.240
Authors: Jieun Kim; Sinyoung Kim; In Sik Hwang; Jong Rak Choi; Jae Geun Lee; Yu Seun Kim; Myoung Soo Kim; Hyun Ok Kim Journal: Ann Lab Med Date: 2017-05 Impact factor: 3.464
Authors: Hye-Jung Yeom; Ok Jae Koo; Jaeseok Yang; Bumrae Cho; Jong-Ik Hwang; Sol Ji Park; Sunghoon Hurh; Hwajung Kim; Eun Mi Lee; Han Ro; Jung Taek Kang; Su Jin Kim; Jae-Kyung Won; Philip J O'Connell; Hyunil Kim; Charles D Surh; Byeong-Chun Lee; Curie Ahn Journal: PLoS One Date: 2012-10-05 Impact factor: 3.240